skip to main content
OSTI.GOV title logo U.S. Department of Energy
Office of Scientific and Technical Information

Title: Identification of $$\mathrm{IOMA}$$-class neutralizing antibodies targeting the $$\mathrm{CD4}$$-binding site on the $$\mathrm{HIV}$$-1 envelope glycoprotein

Journal Article · · Nature Communications
ORCiD logo [1]; ORCiD logo [2];  [1];  [1];  [3];  [1];  [1]; ORCiD logo [1];  [1];  [1];  [2];  [4];  [1];  [4]; ORCiD logo [3];  [2];  [5]; ORCiD logo [3]; ORCiD logo [6];  [4] more »; ORCiD logo [2]; ORCiD logo [2]; ORCiD logo [7]; ORCiD logo [2]; ORCiD logo [1] « less
  1. University of Amsterdam (Netherlands)
  2. The Scripps Research Institute, La Jolla, CA (United States)
  3. Duke University, Durham, NC (United States). Medical Center
  4. Harvard Medical School, Boston, MA (United States)
  5. The Scripps Research Institute, La Jolla, CA (United States); International AIDS Vaccine Initiative, New York, NY (United States)
  6. The Scripps Research Institute, La Jolla, CA (United States); International AIDS Vaccine Initiative, New York, NY (United States); Massachusetts Institute of Technology (MIT), Cambridge, MA (United States)
  7. University of Amsterdam (Netherlands); Cornell University, Ithaca, NY (United States). Weill Medical College

A major goal of current HIV-1 vaccine design efforts is to induce broadly neutralizing antibodies (bNAbs). The VH1-2-derived bNAb IOMA directed to the CD4-binding site of the HIV-1 envelope glycoprotein is of interest because, unlike the better-known VH1-2-derived VRC01-class bNAbs, it does not require a rare short light chain complementarity-determining region 3 (CDRL3). Here, we describe three IOMA-class NAbs, ACS101-103, with up to 37% breadth, that share many characteristics with IOMA, including an average-length CDRL3. Cryo-electron microscopy revealed that ACS101 shares interactions with those observed with other VH1-2 and VH1-46-class bNAbs, but exhibits a unique binding mode to residues in loop D. Analysis of longitudinal sequences from the patient suggests that a transmitter/founder-virus lacking the N276 glycan might have initiated the development of these NAbs. Together these data strengthen the rationale for germline-targeting vaccination strategies to induce IOMA-class bNAbs and provide a wealth of sequence and structural information to support such strategies.

Research Organization:
The Scripps Research Inst., La Jolla, CA (United States); Duke Univ., Durham, NC (United States). Medical Center
Sponsoring Organization:
USDOE Office of Science (SC), Basic Energy Sciences (BES); USDOE Office of Science (SC), Biological and Environmental Research (BER); National Institutes of Health (NIH); HIV Vaccine Research and Design (HIVRAD); Bill and Melinda Gates Foundation; European Union’s Horizon 2020; Netherlands Organization for Scientific Research (NWO)
Grant/Contract Number:
AC02-05CH11231; AC02-76SF00515:P30 GM124169-01; OPP1132237; INV002022; OPP1146996; HHSN272201800004C; 681137
OSTI ID:
1903871
Journal Information:
Nature Communications, Vol. 13, Issue 1; ISSN 2041-1723
Publisher:
Nature Publishing GroupCopyright Statement
Country of Publication:
United States
Language:
English

References (68)

Highly potent HIV-specific antibody neutralization in vitro translates into effective protection against mucosal SHIV challenge in vivo journal October 2012
Virus-like Particles Identify an HIV V1V2 Apex-Binding Neutralizing Antibody that Lacks a Protruding Loop journal May 2017
Broadly Neutralizing Human Anti-HIV Antibody 2G12 Is Effective in Protection against Mucosal SHIV Challenge Even at Low Serum Neutralizing Titers journal May 2009
Immunization for HIV-1 Broadly Neutralizing Antibodies in Human Ig Knockin Mice journal June 2015
Natively glycosylated HIV-1 Env structure reveals new mode for antibody recognition of the CD4-binding site journal September 2016
Broad and Potent Neutralizing Antibodies Recognize the Silent Face of the HIV Envelope journal June 2019
Recent progress in broadly neutralizing antibodies to HIV journal October 2018
The EMBL-EBI search and sequence analysis tools APIs in 2019 journal April 2019
Efficient generation of monoclonal antibodies from single human B cells by single cell RT-PCR and expression vector cloning journal January 2008
Global Panel of HIV-1 Env Reference Strains for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies journal December 2013
Sequence and Structural Convergence of Broad and Potent HIV Antibodies That Mimic CD4 Binding journal July 2011
Automated molecular microscopy: The new Leginon system journal July 2005
MolProbity: More and better reference data for improved all-atom structure validation: PROTEIN SCIENCE.ORG journal November 2017
The expanding array of HIV broadly neutralizing antibodies journal October 2018
A Next-Generation Cleaved, Soluble HIV-1 Env Trimer, BG505 SOSIP.664 gp140, Expresses Multiple Epitopes for Broadly Neutralizing but Not Non-Neutralizing Antibodies journal September 2013
New Member of the V1V2-Directed CAP256-VRC26 Lineage That Shows Increased Breadth and Exceptional Potency journal October 2015
Structural basis for germline antibody recognition of HIV-1 immunogens journal March 2016
Quantitative analysis of cryo-EM density map segmentation by watershed and scale-space filtering, and fitting of structures by alignment to regions journal June 2010
Recombinant HIV envelope trimer selects for quaternary-dependent antibodies targeting the trimer apex journal November 2014
Restriction of HIV-1 Escape by a Highly Broad and Potent Neutralizing Antibody journal February 2020
New tools for automated high-resolution cryo-EM structure determination in RELION-3 journal November 2018
Inference of the HIV-1 VRC01 Antibody Lineage Unmutated Common Ancestor Reveals Alternative Pathways to Overcome a Key Glycan Barrier journal December 2018
Rational Design of Envelope Identifies Broadly Neutralizing Human Monoclonal Antibodies to HIV-1 journal July 2010
MotionCor2: anisotropic correction of beam-induced motion for improved cryo-electron microscopy journal February 2017
HIV-1 Fitness Cost Associated with Escape from the VRC01 Class of CD4 Binding Site Neutralizing Antibodies journal January 2015
Human Immunodeficiency Virus Type 1 env Clones from Acute and Early Subtype B Infections for Standardized Assessments of Vaccine-Elicited Neutralizing Antibodies journal July 2005
Effects of CCR5 and CD4 Cell Surface Concentrations on Infections by Macrophagetropic Isolates of Human Immunodeficiency Virus Type 1 journal April 1998
Design and crystal structure of a native-like HIV-1 envelope trimer that engages multiple broadly neutralizing antibody precursors in vivo journal August 2017
Inference of Macromolecular Assemblies from Crystalline State journal September 2007
Development and implementation of an international proficiency testing program for a neutralizing antibody assay for HIV-1 in TZM-bl cells journal January 2012
UCSF Chimera?A visualization system for exploratory research and analysis journal January 2004
An HIV-1 antibody from an elite neutralizer implicates the fusion peptide as a site of vulnerability journal November 2016
Neutralizing Antibody Responses Induced by HIV-1 Envelope Glycoprotein SOSIP Trimers Derived from Elite Neutralizers journal November 2020
Broadly resistant HIV-1 against CD4-binding site neutralizing antibodies journal June 2019
Gctf: Real-time CTF determination and correction journal January 2016
Structure and immunogenicity of a stabilized HIV-1 envelope trimer based on a group-M consensus sequence journal May 2019
The human naive B cell repertoire contains distinct subclasses for a germline-targeting HIV-1 vaccine immunogen journal July 2018
Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1 journal July 2014
Structural Basis for Broad and Potent Neutralization of HIV-1 by Antibody VRC01 journal July 2010
IMGT/V-QUEST: the highly customized and integrated system for IG and TR standardized V-J and V-D-J sequence analysis journal May 2008
Priming HIV-1 broadly neutralizing antibody precursors in human Ig loci transgenic mice journal September 2016
Saturation Mutagenesis of the HIV-1 Envelope CD4 Binding Loop Reveals Residues Controlling Distinct Trimer Conformations journal November 2016
Current developments in Coot for macromolecular model building of Electron Cryo‐microscopy and Crystallographic Data journal March 2020
Identification of a CD4-Binding-Site Antibody to HIV that Evolved Near-Pan Neutralization Breadth journal November 2016
B cells expressing authentic naive human VRC01-class BCRs can be recruited to germinal centers and affinity mature in multiple independent mouse models journal September 2020
Emergence of Resistant Human Immunodeficiency Virus Type 1 in Patients Receiving Fusion Inhibitor (T-20) Monotherapy journal June 2002
CATNAP: a tool to compile, analyze and tally neutralizing antibody panels journal June 2015
Building and rebuilding N-glycans in protein structure models journal April 2019
EMRinger: side chain–directed model and map validation for 3D cryo-electron microscopy journal August 2015
A Native-Like SOSIP.664 Trimer Based on an HIV-1 Subtype B env Gene journal January 2015
Longitudinal Analysis of Early HIV-1-Specific Neutralizing Activity in an Elite Neutralizer and in Five Patients Who Developed Cross-Reactive Neutralizing Activity journal February 2012
Mechanism of Neutralization by the Broadly Neutralizing HIV-1 Monoclonal Antibody VRC01 journal June 2011
Fusion peptide of HIV-1 as a site of vulnerability to neutralizing antibody journal May 2016
Refinement of Protein Structures into Low-Resolution Density Maps Using Rosetta journal September 2009
SAbPred: a structure-based antibody prediction server journal April 2016
Vaccine genetics of IGHV1-2 VRC01-class broadly neutralizing antibody precursor naïve human B cells journal September 2021
Cross‐Reactive Neutralizing Humoral Immunity Does Not Protect from HIV Type 1 Disease Progression journal April 2010
Passive transfer of modest titers of potent and broadly neutralizing anti-HIV monoclonal antibodies block SHIV infection in macaques journal August 2014
Structural Repertoire of HIV-1-Neutralizing Antibodies Targeting the CD4 Supersite in 14 Donors journal June 2015
Mapping Polyclonal HIV-1 Antibody Responses via Next-Generation Neutralization Fingerprinting journal January 2017
Structural basis for germ-line gene usage of a potent class of antibodies targeting the CD4-binding site of HIV-1 gp120 journal June 2012
A single, continuous metric to define tiered serum neutralization potency against HIV journal January 2018
Stock-based detection of protein oligomeric states in jsPISA journal April 2015
Coexistence of potent HIV-1 broadly neutralizing antibodies and antibody-sensitive viruses in a viremic controller journal January 2017
Rational design and in vivo selection of SHIVs encoding transmitted/founder subtype C HIV-1 envelopes journal April 2019
Multidonor Analysis Reveals Structural Elements, Genetic Determinants, and Maturation Pathway for HIV-1 Neutralization by VRC01-Class Antibodies journal August 2013
cryoSPARC: algorithms for rapid unsupervised cryo-EM structure determination journal February 2017
Priming a broadly neutralizing antibody response to HIV-1 using a germline-targeting immunogen journal June 2015

Cited By (10)

Accurate Prediction for Antibody Resistance of Clinical HIV-1 Isolates journal October 2019
Correction for Hraber et al., “Panels of HIV-1 Subtype C Env Reference Strains for Standardized Neutralization Assessments” journal January 2018
Maternal but Not Infant Anti-HIV-1 Neutralizing Antibody Response Associates with Enhanced Transmission and Infant Morbidity journal October 2017
A Bispecific Antibody That Simultaneously Recognizes the V2- and V3-Glycan Epitopes of the HIV-1 Envelope Glycoprotein Is Broader and More Potent than Its Parental Antibodies journal January 2020
Broadly neutralizing antibodies: What is needed to move from a rare event in HIV-1 infection to vaccine efficacy? journal July 2018
Mathematical modeling to reveal breakthrough mechanisms in the HIV Antibody Mediated Prevention (AMP) trials journal February 2020
Cross-Neutralizing Antibodies in HIV-1 Individuals Infected by Subtypes B, F1, C or the B/Bbr Variant in Relation to the Genetics and Biochemical Characteristics of the env Gene journal December 2016
Guiding the humoral response against HIV-1 toward a MPER adjacent region by immunization with a VLP-formulated antibody-selected envelope variant journal December 2018
Diverse pathways of escape from all well-characterized VRC01-class broadly neutralizing HIV-1 antibodies journal August 2018
Broadly resistant HIV-1 against CD4-binding site neutralizing antibodies journal June 2019